![Cancers | Free Full-Text | Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know? | HTML Cancers | Free Full-Text | Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know? | HTML](https://www.mdpi.com/cancers/cancers-13-03193/article_deploy/html/images/cancers-13-03193-g001.png)
Cancers | Free Full-Text | Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know? | HTML
![SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines | Cancer Genomics & Proteomics SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines | Cancer Genomics & Proteomics](https://cgp.iiarjournals.org/content/cgp/19/1/50/F1.large.jpg)
SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines | Cancer Genomics & Proteomics
![SciELO - Brasil - The paradox of autophagy in Tuberous Sclerosis Complex The paradox of autophagy in Tuberous Sclerosis Complex SciELO - Brasil - The paradox of autophagy in Tuberous Sclerosis Complex The paradox of autophagy in Tuberous Sclerosis Complex](https://minio.scielo.br/documentstore/1678-4685/qLfWzprCBcWxLLyrFTwrHjM/ed4e144022721159090000edd641519164f8f05e.jpg)
SciELO - Brasil - The paradox of autophagy in Tuberous Sclerosis Complex The paradox of autophagy in Tuberous Sclerosis Complex
Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
![HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/04/02/2020.04.01.020446/F2.large.jpg)
HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND METABOLIC REPROGRAMMING TOWARDS CELLULAR STEMNESS AS ADAPTATION TO INHIBITION OF THE AKT PATHWAY | bioRxiv
![Akt im Sternenstaub EvE fotografiert von Rainer Matthias Gillessen (Wandkalender 2017 DIN A4 hoch): AKT Kalender von RMG und EVE (Monatskalender, 14 Seiten ) : Amazon.es: Libros Akt im Sternenstaub EvE fotografiert von Rainer Matthias Gillessen (Wandkalender 2017 DIN A4 hoch): AKT Kalender von RMG und EVE (Monatskalender, 14 Seiten ) : Amazon.es: Libros](https://images-na.ssl-images-amazon.com/images/I/51cOh91QQyL._SX352_BO1,204,203,200_.jpg)
Akt im Sternenstaub EvE fotografiert von Rainer Matthias Gillessen (Wandkalender 2017 DIN A4 hoch): AKT Kalender von RMG und EVE (Monatskalender, 14 Seiten ) : Amazon.es: Libros
![MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation](https://www.spandidos-publications.com/article_images/ijo/54/5/IJO-54-05-1833-g02.jpg)
MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
![Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance | Leukemia Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0305-8/MediaObjects/41375_2018_305_Fig2_HTML.png)
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance | Leukemia
![Metformin: An old drug against old age and associated morbidities - Diabetes Research and Clinical Practice Metformin: An old drug against old age and associated morbidities - Diabetes Research and Clinical Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d0944d9f-2b36-4004-beb2-e20e3e97a3c7/gr1_lrg.jpg)
Metformin: An old drug against old age and associated morbidities - Diabetes Research and Clinical Practice
![Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development](https://f6publishing.blob.core.windows.net/dad7b082-c01a-4c65-b571-093933aaa2d5/WJG-25-1797-g001.png)
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
![The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf7561/asset/961dc8db-1aa2-427a-bc64-d1bc13ef9749/assets/images/large/sciadv.abf7561-f1.jpg)
The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output | Science Advances
![Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway - ScienceDirect Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S002432051830314X-gr3.jpg)
Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway - ScienceDirect
![Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin | Nature Communications Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-017-02733-4/MediaObjects/41467_2017_2733_Fig1_HTML.jpg)
Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin | Nature Communications
![Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target? Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?](https://www.frontiersin.org/files/Articles/730048/fphys-12-730048-HTML/image_m/fphys-12-730048-t001.jpg)